Please login to order a test.
GJB2 Sequencing, Family-targeted (Single Exon Sequencing−Known Mutation)
- Connexin 26
- Hearing Loss (GJB2)
This test only covers the exon or amplicon that harbors the variant(s) of interest. Other regions of the gene will not be examined.
Detects known familial mutations in the connexin 26 (GJB2) gene associated with nonsyndromic sensorineural hearing loss (NSHL). This option is available when the mutation is known and can be documented by the ordering physician. If the mutation cannot be documented, please order full gene sequencing.
This method does not reliably detect mosaic variants; large deletions; large duplications, inversions, or other rearrangements; deep intronic variants or variants outside of the regions targeted by this analysis. It may be affected by allele-dropout, it may not allow determination of the exact numbers of T/A or microsatellite repeats, and it does not allow any conclusion as to whether two heterozygous variants are present on the same or on different chromosome copies.
Connexin 26 is one of the most significant genes involved in congenital, nonsyndromic, sensorineural hearing loss (NSHL, OMIM 220920) (GJB2, OMIM 121011). Connexin 26 produces a protein that directs the intracellular transfer of ions and molecules that are important in hearing. GJB2 is associated with both autosomal recessive (DFNB1) and autosomal dominant (DFNA3) hearing loss.
Whole blood, buccal swab, amniotic fluid, or chorionic villus sample (CVS) (Submission of maternal blood is required for fetal testing.)
7 mL whole blood, 4 buccal swabs, 10 mL amniotic fluid, or 20 mg CVS
3 mL whole blood, 2 buccal swabs, 5 mL amniotic fluid, or 10 mg CVS
Maintain specimen at room temperature or refrigerate at 4°C.
Causes for Rejection
Frozen specimen; hemolysis; quantity not sufficient for analysis; improper container; wet buccal swab